Learn about some of the exciting news and events going on around the McDonnell Genome Institute.
Whole genome sequencing shows promise in routine treatment of blood cancers, Washington U. study says (Links to an external site)
Michele Munz ST. LOUIS — Washington University researchers are among the first to show that whole genome sequencing, which used to be time-consuming and expensive, can be used routinely in patient care.
Promising role for whole genome sequencing in guiding blood cancer treatment (Links to an external site)
Sequencing results returned in a few days; costs similar to conventional testing by Julia Evangelou Strait•March 10, 2021
Research Reveals How COVID-19 Can Kill Heart Muscle Cells, Interfere With Contraction (Links to an external site)
By WASHINGTON UNIVERSITY SCHOOL OF MEDICINE MARCH 2, 2021 Study reveals details of how coronavirus infects heart; models of tissue damage may help develop potential therapies.
Antibody-based COVID-19 treatments work best in concert with immune cells (Links to an external site)
Findings involving antibody effector functions could help improve design of next-generation COVID-19 antibody drugs
Glioblastoma Omics Study Highlights Informative Tumor Features, Immune Subtypes (Links to an external site)
By Staff Reporter NEW YORK – A team from Washington University, the Pacific Northwest National Laboratory, and elsewhere has identified immune subgroups in glioblastoma (GBM) that may ultimately help in developing more effective immunotherapy approaches against aggressive brain cancer.
